PTLA News and Press, Portola Pharmaceuticals Inc. From 05/14/20

SOUTH SAN FRANCISCO, Calif. , May 14, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has proposed extending the New Technology Add-on Payment (NTAP) for Andexxa ®  [coagula...

Calling a purchase of Portola Pharmaceuticals (NASDAQ: PTLA ) the "wrong direction," Elliott Advisors suggests Alexion (NASDAQ: ALXN ) instead put itself on the block. More news on: Alexion Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Me...

Portola Pharmaceuticals (NASDAQ: PTLA ): Q1 GAAP EPS of -$0.88 misses by $0.21 . Revenue of $26.4M (+18.9% Y/Y) misses by $7.82M . Press Release More news on: Portola Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,

NEW YORK, NY / ACCESSWIRE / May 11, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the p...

Merger activity increased last week with three new deals announced, four deals closing and one deal terminated. After a three-week lull, merger activity picked up again with three new deals announced. The hard-hit energy services industry saw the merger of KLX Energy Services Holdings (KLX...

Portola Pharmaceuticals (NASDAQ: PTLA ): Q1 GAAP EPS of -$0.88 misses by $0.07 . More news on: Portola Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

SOUTH SAN FRANCISCO, Calif. , May 11, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today reported financial results for the three months ended March 31, 2020, and provided a corporate update, including the Company's actions to continue to su...

Alexion Pharmaceuticals ( ALXN ) surprised the market by announcing an acquisition in the middle of the Covid-19 crisis as it is looking to acquire Portola Pharmaceuticals ( PTLA ) . Thanks to generous cash flows, Alexion has the means and willingness to be aggressive in dealmaking, havin...

By Breakingviews Alexion Pharmaceuticals (ALXN) is either buying Portola Pharmaceuticals (PTLA) on the cheap at $1.4 billion, or paying a whopping premium - it all depends on your starting date. The deal means the $22 billion biotech snaps up a promising drug to reverse anticoagulants. The...

NEW YORK, NY / ACCESSWIRE / May 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the pr...